January 11, 2026

Parabilis Medicines

Round: Series F
Amount raised: $305M
Lead investor: RA Capital Management & Fidelity Management & Research Company
Industry: Biotechnology Research
Headquarters: United States
Employees: —
Website: —
LinkedIn: View profile →